Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of Wholegrain Wheat on Body Weight and Composition and Cardiovascular Risk (HEALTHGRAIN)

This study has been completed.
BARILLA G. e R. Fratelli S.p.A., Parma, Italy
the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008)
Information provided by:
University of Copenhagen Identifier:
First received: March 25, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
The aim of this study is to investigate the potential beneficial effect of wholegrain on body weight and composition as well as cardiovascular risk in overweight women.

Condition Intervention
Other: wholegrain
Other: refined wheat

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Healthgrain WP 4.4.3: Effects of Whole Grain on Weight Maintenance/Weight Reduction in Overweight Subjects

Resource links provided by NLM:

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Body weight and composition [ Time Frame: 0, 6 and 12 wks ]

Secondary Outcome Measures:
  • Cardiovascular risk markers [ Time Frame: 0, 6 and 12 wks ]
  • Fecal parameters [ Time Frame: 0 and 12 wks ]

Enrollment: 85
Study Start Date: August 2007
Study Completion Date: December 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: WW
wholegrain wheat
Other: wholegrain
wholegrain wheat vs. refined wheat products
Active Comparator: RW
refined wheat
Other: refined wheat
refined wheat products

Detailed Description:

Objective: To study the effect of the 'wholegrain concept', i.e. high intake of wheat wholegrain (WW) vs. refined wheat (RW) grain products on body weight and composition.

Design: In this open-labeled randomized trial, 72 postmenopausal women with metabolic syndrome features were prescribed a mild calorie-restricted diet with a deficit of ~1,250kJ/d. Following 2 weeks run-in period on RW products, they were randomized to 12 weeks intervention with RW or WW products providing 2,000kJ/d.


Ages Eligible for Study:   40 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • BMI 27-37
  • Postmenopausal (>1y) women
  • 40-70 years old

Exclusion Criteria:

  • Medication (hypertensive treatment not included)
  • BP > 160/100
  • Fasting glucose > 7mM
  • Fasting cholesterol > 6.5mM
  • Smoking
  • Known chronic illnesses
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00869531

University of Copenhagen, Department og Human Nutrition
Frederiksberg C, Denmark, 1958
Sponsors and Collaborators
University of Copenhagen
BARILLA G. e R. Fratelli S.p.A., Parma, Italy
the European Commission in the Communities 6th Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008)
  More Information

Additional Information:
Responsible Party: Arne Astrup, University of Copenhagen Identifier: NCT00869531     History of Changes
Other Study ID Numbers: B223
Study First Received: March 25, 2009
Last Updated: March 25, 2009

Keywords provided by University of Copenhagen:
cardiovascular disease processed this record on May 22, 2017